Clinical Trial Update: Trial of Nivolumab and Cetuximab After Chemoradiation in Esophageal Squamous Cell Carcinoma Patients. [Phase 2]

View source ↗

Summary

This update covers a Phase 2 trial evaluating nivolumab in combination with cetuximab after chemoradiation for esophageal squamous cell carcinoma, with the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• ERBITUX (cetuximab)
• Opdivo (nivolumab) (nivolumab)

Snippet

Sponsor: Baruch Brenner | Conditions: Esophageal Squamous Cell Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING